STIM — Neuronetics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1227636 ·
Last close
$1.28
Market Cap
$99.49M
52W High
$3.44
52W Low
$0.80
ADV30
2,330,593
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 41,962,000 | 21,890,000 | 541,000 | -1,692,000 | 131,958,000 | 22,106,000 | 109,555,000 |
| Jun 2026 | 41,568,000 | 21,223,000 | -1,501,000 | -3,439,000 | 131,529,000 | 19,197,000 | 109,889,000 |
| Mar 2026 | 34,454,000 | 16,154,000 | -8,995,000 | -10,790,000 | 125,440,000 | 13,214,000 | 108,380,000 |
| Dec 2025 | 41,777,000 | 21,704,000 | -5,043,000 | -7,158,000 | 141,551,000 | 28,134,000 | 115,311,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-8,283,000
Investing CF
$-1,275,000
Financing CF
$2,943,000
CapEx
$-1,300,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.33
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-474,843,000
Inventory
$4,943,000
Receivables
$14,693,000
ST Investments
$250,000
EBIT TTM
$-15,053,000
Pretax Income TTM
$-22,953,000
Interest Exp TTM
$7,900,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$155,096,000
EBITDA
$-19,263,000
Free Cash Flow
$345,625
Enterprise Value
$277,229,472
Total Cash
$19,197,000
Total Debt
$86,523,000
Shares Out
77,728,311
Trailing EPS
$-0.32
Book Value
$0.32
ROE
-116.1%
ROA
-10.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 149,157,000 | -31,436,000 | -38,998,000 | 141,551,000 | 115,311,000 | 22,378,000 | -20,374,000 |
| Dec 2024 | 74,890,000 | -34,563,000 | -43,708,000 | 140,903,000 | 109,104,000 | 27,706,000 | -30,997,000 |
| Dec 2023 | 71,348,000 | -30,554,000 | -30,189,000 | 115,831,000 | 81,641,000 | 34,190,000 | -32,038,000 |
| Dec 2022 | 65,206,000 | -35,111,000 | -37,159,000 | 116,884,000 | 59,824,000 | 57,060,000 | -30,739,000 |
TTM Snapshot
Revenues TTM
$155,096,000
NetIncome TTM
$-30,432,000
OpCashFlow TTM
—
Assets (Latest)
$131,529,000
Forward EPS
$-0.30
Max Pain — expiry 2027-02-19
max pain strike: $2.00 · spot: $1.25 · call oi: 1,000 · put oi: 103
Expected Move to 2027-02-19:
±$0.60
(48.00%) —
implied range
$0.65 –
$1.85
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VANI | Vivani Medical, Inc. | $94.71M | $1.05 | — |
| APYX | Apyx Medical Corp | $107.63M | $2.56 | — |
| NYXH | Nyxoah SA | $91.65M | $0.90 | — |
| SKIN | SkinHealth Systems Inc. | $90.40M | $13.88 | — |
| STXS | Stereotaxis, Inc. | $88.39M | $0.88 | — |
News headlines (Yahoo Finance, 1h cache)
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-11-18 22:41 · Yahoo
Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
2026-11-11 03:39 · Yahoo
Neuronetics stock tumbles 10% on stock offering launch
2026-11-10 21:39 · Yahoo
Neuronetics Announces Proposed Public Offering of Common Stock
2026-11-10 21:01 · Yahoo
Neuronetics Inc (STIM) (Q3 2026) Earnings Call Highlights: Revenue Jumps 12. ...
2026-11-05 03:07 · Yahoo
Neuronetics Q3 Earnings Call Highlights
2026-11-04 21:14 · Yahoo
Neuronetics, Inc. Q3 2026 Earnings Call Summary
2026-11-04 18:13 · Yahoo
Neuronetics (STIM) Q3 2026 Earnings Call Transcript
2026-11-04 17:58 · Yahoo
Neuronetics Reports 12.5% Revenue Growth to $42 Million in Q3 2026 as Losses Narrow
2026-11-04 15:34 · Yahoo
Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates
2026-11-04 14:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.